Our comprehensive portfolio of services enables organizations to:
Maintain compliance and minimize regulatory risk
Strengthen clinical research practices
Protect the safety and welfare of clinical trial participants
Develop and establish a robust research administration strategy
Institutional Review Board Services
Advarra is the largest integrated provider of IRB services with the greatest institutional reach, serving over 3,500 health systems, cancer centers, and academic medical centers. Powered by the Advarra Center for IRB Intelligence (CIRBI) Platform, Advarra IRB services deliver faster access to information, easier record management, and secure communication tools while reinforcing high-integrity study conduct and regulatory compliance to streamline the review process.
Institutional Biosafety Committee Services
Advarra IBC services provide comprehensive review and oversight of clinical trials involving gene therapy and gene modified cellular therapy and genetically engineered vaccine research. Our growing network of Gene Therapy Ready sites are pre-registered, vetted, and standing by to conduct your clinical trial. Leverage the world’s largest integrated IRB and IBC service to move your clinical trials forward — faster.
Advarra Consulting works with pharmaceutical, medical device, and biopharmaceutical organizations to solve mission-critical challenges and to bring life-changing therapies to patients faster. Our team of expert consultants, organized in Centers of Excellence specializing in Quality, Regulatory, Clinical, and Institutional Research, are experienced industry practitioners—alumni from some of the most respected companies in the world—offering their extensive hands-on experience to provide outcome-oriented solutions across the product development lifecycle.
Informed Consent Development
While there are many important aspects of a clinical research trial, the trial itself wouldn’t happen without research participants. A successful study depends on recruiting and retaining clinical research participants. Failing to craft a comprehensive, easy-to-read informed consent form can result in uninformed participants and lower trial retention rates. Advarra’s experts have the ability to translate a protocol document into a compliant and understandable consent document, ensuring your clinical trial documentation and study activation is more efficient.
Leverage our experience in conducting coverage analysis for drug and device studies, customized in accordance with standards and local Medicare policies. Streamline the study startup process and effectively build clinical trial budgets.
World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed
Advarra’s IRB and IBC reviews and Gene Therapy Ready site network helped reduce study startup timelines and delivered trial results to the sponsor quicker than expected.
Advarra Publishes the State of Clinical Trial Activation at Sites Report
Advarra has published a report providing actionable solutions to streamline study activation and maximize operational efficiency
Global CRO Drives Study Startup Efficiency by Converting Local IRB Sites to Central IRB Review
Research sites that rely on a local IRB typically take at least twice as long to activate than sites that rely on the study’s single central IRB. Utilizing the central ...